One of the main objections to the health reform is bill making its way through congress that it can have a negative impact on medical innovation. The expert Dr. Francis Collins has warned that an Obama administration focus on the comparative effectiveness studies, designed to reduce health care costs, could jeopardize this new area. Studies on the comparative effectiveness of the detection of the treatment of disease it works better. The plans of medical insurance those, including proposed to public version, it will cover the successful treatment of preparations. The use of this method can decrease billions of dollars, spent on aid it is ineffective, and also reduction in the insurance rewards as the result.
The future of prescription drugs can be activated through personalized medicine. New drugs is accompanied by a diagnostic test is currently formulated and approved by the FDA. Testing of biomarkers in the body will allow more individualized, effective treatment. These drugs will be increasingly important role in the future. Using genetics, the laboratory could eventually understand, for the treatment of chronic diseases, health insurance costs billions. At least, for the treatment of these conditions will be more effective than some equally expensive drugs out there today. Bill of health reform can contribute to scientific research in these areas, companies such as X. While the federal government provides grants for genetic research, their financial support may be reduced since the burden of comprehensive health care reform.
More expensive in the short run personalized medicine has the potential to save more money, if included in health reform. About 50,000 women benefited from testing this year, and many of them found that they are at low risk for cancer with relapse. Studies have shown that most women are judged as a low risk of recurrence has decided not to chemotherapy. This choice of each patient saving $ 2000, as well as their health insurance plans of thousands of people that would be spent on chemotherapy. Ultimately, this will help reduce the cost of cancer health insurance and make it more accessible. Women also benefit from not experiencing the exhausting procedure, which may not be needed.
Important significance has in all in the expenditure control for the plans of medical insurance. Nevertheless, economizing money they can visit them too far and negatively influence the quality of care of those, who are already insured. For a period of decades the United States it was famous to its achievements in the medical technology, but some measures assume that actual of the health of our population lags behind other industrially developed countries only by less innovation equipment. Personalized medicine by genetic testing is the X, which also can serve for an improvement in preventive maintenance and diagnostics of diseases. It has a potential to become worthy of investment for the future generations of Americans.
The future of prescription drugs can be activated through personalized medicine. New drugs is accompanied by a diagnostic test is currently formulated and approved by the FDA. Testing of biomarkers in the body will allow more individualized, effective treatment. These drugs will be increasingly important role in the future. Using genetics, the laboratory could eventually understand, for the treatment of chronic diseases, health insurance costs billions. At least, for the treatment of these conditions will be more effective than some equally expensive drugs out there today. Bill of health reform can contribute to scientific research in these areas, companies such as X. While the federal government provides grants for genetic research, their financial support may be reduced since the burden of comprehensive health care reform.
More expensive in the short run personalized medicine has the potential to save more money, if included in health reform. About 50,000 women benefited from testing this year, and many of them found that they are at low risk for cancer with relapse. Studies have shown that most women are judged as a low risk of recurrence has decided not to chemotherapy. This choice of each patient saving $ 2000, as well as their health insurance plans of thousands of people that would be spent on chemotherapy. Ultimately, this will help reduce the cost of cancer health insurance and make it more accessible. Women also benefit from not experiencing the exhausting procedure, which may not be needed.
Important significance has in all in the expenditure control for the plans of medical insurance. Nevertheless, economizing money they can visit them too far and negatively influence the quality of care of those, who are already insured. For a period of decades the United States it was famous to its achievements in the medical technology, but some measures assume that actual of the health of our population lags behind other industrially developed countries only by less innovation equipment. Personalized medicine by genetic testing is the X, which also can serve for an improvement in preventive maintenance and diagnostics of diseases. It has a potential to become worthy of investment for the future generations of Americans.
No comments:
Post a Comment